Dr. Sarah Gheuens
Equibles does not estimate personal net worth.
About Dr. Sarah Gheuens
Dr. Sarah Gheuens was last confirmed as Board Member at Viridian Therapeutics, Inc.\DE (VRDN) in a filing dated April 26, 2024. Viridian Therapeutics, Inc.\DE reported in an 8-K filed September 25, 2023 that Dr. Sarah Gheuens was appointed Class I director, effective September 21, 2023.
“Effective September 21, 2023, the Board of Directors (the “Board”) of Viridian Therapeutics, Inc. (the “Company”) increased the size of the Board from five to six directors and appointed a new director, Dr. Sarah Gheuens, to serve as a Class I director to hold office until the 2025 Annual Meeting of Stockholders and until her successor shall have been duly elected and qualified.”
Affiliation history
-
Start not stated–2024-04-26
Last confirmed by a filing; no departure on record